Collegium Pharmaceutical, Inc. COLL Other Commercial Liabilities
Other Commercial Liabilities at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s other commercial liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s other commercial liabilities?
- Collegium Pharmaceutical, Inc. (COLL) reported other commercial liabilities of $58.15M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s other commercial liabilities changed year-over-year?
- Collegium Pharmaceutical, Inc.'s other commercial liabilities increased by 8.2% year-over-year, from $53.74M to $58.15M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s other commercial liabilities?
- Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s other commercial liabilities has grown at a 20.4% compound annual growth rate (CAGR), from $24.66M to $62.46M.